The Impact of Total Control of Antibiotic Prescribing by Infectious Disease Specialist on Antibiotic Consumption and Cost

References

• Anon. Decision No. 1350/2007/EC of the European par-liament and the council of 23 October 2007 establishing a sec-ond programme of the Community action in the field of health (2008-13). Official Journal of the European Journal L 2007; 301: 3–13.
   Google Scholar
• Davey P, Brown E, Fenelon L, Gould I, Hartman G, Holmes A, et al. Interventions to improve antibiotic prescribing for hospital inpatients (Review). Cochrane Database Syst Rev 2005; 4: CD003543.
   PubMedGoogle Scholar
• Dellit TH, Owens RC, McGowan JE, Gerding DN, Wein-stein RA, Burke JP, et al. Infectious diseases society of America and Society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44 (2): 159–177.
   PubMed Web of Science ®Google Scholar
• www.whocc.no/atcddd/
   Google Scholar
• Armitage P. Statistical Methods in Medical Research. Ox-ford: Blackwell Scientific Publications. 1980.&
   Google Scholar
• McGowan JE, Findland M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis 1974; 130 (2): 165–168.
   PubMed Web of Science ®Google Scholar
• Craig WA, Uman SJ, Shaw WR, Ramgopal V, Eagan LL, Leopold ET. Hospital use of antimicrobial drugs. Survey at 19. hospitals and results of antimicrobial control program. Ann Intern Med 1978; 89 (5Pt 2 Suppl): 793-795.
   Google Scholar
• Recco RA, Gladstone JL, Friedman SA Gerken EH. An-tibiotic control in a municipal hospital. JAMA 1979; 241 (21): 2283–2286.
   Google Scholar
• Seligman SJ. Reduction in antibiotic costs by restricting use of an oral cephalosporin. Am J Med 1981; 71 (6): 941-944.1°
   Google Scholar
• Huber SL, Patry RA, Hudson HD. Influencing drug use through prescribing restrictions. Am J Hosp Pharm 1982; 39 (11): 1989–1901.
   Google Scholar
• Hayman JN, Sbravati EC. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics com-mittee restrictions. Am J Hosp Pharm 1985; 42 (6): 1343–1347.
   PubMedGoogle Scholar
• Moleski RJ, Andriole VT. Role of an infectious disease spe-cialist in containing costs of antibiotics in the hospital. Rev Infect Dis 1986; 8 (3): 488–493.
   PubMedGoogle Scholar
• Woodward RS, Medoff G, Smith MD, Gray JL 3rd. An-tibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987; 83 (5): 817-823.
   PubMed Web of Science ®Google Scholar
• Hirschman SZ, Meyers BR, Bradbury K, Mehl B, Gendel-man S, Kimelblatt B. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control pro-gram. Arch Intern Med 1988; 148 (9): 2001–2007.
   PubMedGoogle Scholar
• Gerding DN, Larson TA, Hughes RA, Weiler M, Shan-holtzer C, Peterson LR. Aminoglycoside resistance and amino-glycoside usage: ten years experiences in one hospital. Antimicrob Agents Chemother 1991; 35 (7): 1284–1290.
   PubMedGoogle Scholar
• Coleman RW, Rodondi LC, Kaubisch S, Granzella NB, O'Hanley PD. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto veterans affairs medical center from 1987 to 1989. Am J Med 1991; 90 (4): 439–444.
   PubMed Web of Science ®Google Scholar
• Suwangool P, Moola-Or P, Waiwatana A, Sitthi-Amorn C, Israsena S, Hanvanich M. Effect of a selective restriction pol-icy on antibiotic expenditure and use: an institutional model. J Med Assoc Thai 1991; 74 (7): 272–275.
   PubMedGoogle Scholar
• Himmelberg CJ, Pleasants RA, Weber DJ, Kessler JM, Samsa GP, Spivey JM. Use of antimicrobial drugs in adults be-fore and after removal of a restriction policy. Am J Public Health 1991; 48 (6): 1220–1227.
   Web of Science ®Google Scholar
• Bamberger DM, Dahl SL. Impact of voluntary vs enforced compliance of third-generation cephalosporins use in a teaching hospital. Arch Intern Med 1992; 152 (3): 554-557.2°
   Google Scholar
• King JW, White MC, Todd JR, Conrad SA. Alterations in the microbial flora and the incidence of bacteremia at a univer-sity hospital after adoption of amikacin as the sole formulary aminoglycoside. Clin Infect Dis 1992; 14 (4): 908–915.
   PubMed Web of Science ®Google Scholar
• Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-gen-eration cephalosporins. Ann Intern Med 1993; 119 (5): 353–358.
   PubMed Web of Science ®Google Scholar
• Belliveau PP, Rothman AL, Maday CE. Limiting van-comycin use to combat vancomycin-resistant Enterococcus fae-cium. Am J Health Syst Pharm 1996; 53 (13): 1570–1575.
   PubMed Web of Science ®Google Scholar
• Salama S, Rotstein C, Mandell L. A multidisciplinary hos-pital-based antimicrobial use program: impact on hospital phar-macy expenditure and drug use. Can J Infect Dis 1996; 7 (5): 104–109.
   PubMedGoogle Scholar
• White AC Jr, Atmar RL, Wilson J, Cate TR, Stagner CE, Greenberg SB. Effects of requiring prior authorization for se-lected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25 (2): 230–239.
   PubMed Web of Science ®Google Scholar
• CliMo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998; 128 (12 Pt1): 989-995.
   Google Scholar
• Rahal JJ, Urban C, Horn D, Freeman K, Segalmaurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280 (14): 1233–1237.
   PubMed Web of Science ®Google Scholar
• Sirinavin S, Suvanakoot P, Sathapatayavongs D, Malatham K. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment. Southeast Asian J Trop Med Public Health 1998; 29 (3): 636–642.
   PubMedGoogle Scholar
• Mercer KA, Chintalapudi SR, Visconti EB. Impact of tar-geted antibiotic restriction on usage and cost in a community hos-pital. J Pharm Technol 1999; 15 (2): 79–84.
   Google Scholar
• Leverstein-van Hall MA, Fluit AC, Blok HE, Box AT, Pe-ters ED, Weersink AJ, et al. Control of nosocomial multiresistant Enterobacteraceae using a temporary restrictive antibiotic agent policy. Eur J Clin Microbiol Infect Dis 2001; 20 (11): 785–791.
   PubMed Web of Science ®Google Scholar
• Richards MJ, Robertson MB, Dartnell JG, Duarte MM, Jones NR, Kerr DA et al. Impact of a web-based antimicrobial ap-proval system on broad-spectrum cephalosporin use at a teach-ing hospital. Med J Aust 2003; 178 (8): 386–390.
   Google Scholar
• Landman D, Chockalingam M, Qualy JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus andceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28 (5): 1062–1066.
   PubMed Web of Science ®Google Scholar
• McElnay JC, Scott MG, Sidara JY, Keraney P. Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies. Pharm World Sci 1995; 17 (6): 207–213.
   PubMedGoogle Scholar
• Lautenbach E, LaRosa LA, Marr AM, Nakhamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-re-sistant enterococci in response to antimicrobial formulary inter-ventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003; 36 (4): 440–446.
   PubMed Web of Science ®Google Scholar
• Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, The-bault A, Chonaid C. Impact of a mutidisciplinaty approach to the control of antibiotic prescription in a general hospital. J Hosp In-fect 2003; 53 (3): 177–182.
   PubMed Web of Science ®Google Scholar
• Akalin H, Kahveci F, Ozakin C, Helvaci S, Gedikoglu S, Kutlay 0, et al. Influences at alternate therapy protocol and con-tinuous infectious disease consultation on antibiotic susceptibility in ICU. Intensive Care Med 1999; 25 (9): 1010–2.
   Google Scholar
• www. rivm . nl/earss/database/
   Google Scholar